MedTrace Logo

PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study

NCT05542485 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2023-12-15

No results posted yet for this study

Summary

This is a multi-centre, prospective, translational study investigating the use of plasma genotyping for initial genomic testing in newly diagnosed advanced/locally advanced non-squamous NSCLC.

In this study, patients will have a plasma genotyping assay completed following confirmation of suspected diagnosis of non-squamous NSCLC at institutional Rapid Access Lung Cancer Clinics (RALCC), alongside standard tissue-based biopsy and genotyping.

Conditions

Interventions

DIAGNOSTIC_TEST

ctDNA liquid biopsy - Roche Avenio Assay

The intervention will involve plasma ctDNA testing for patients with a radiological suspicion for newly diagnosed advanced NSCLC

Sponsors & Collaborators

  • Royal College of Surgeons, Ireland

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-06
Primary Completion
2024-10-01
Completion
2025-12-01

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05542485 on ClinicalTrials.gov